文献速递主动脉疾病

腹主动脉瘤筛查:疗效与成本效益的系统综述与Meta分析

Abdominal Aortic Aneurysm Screening: A Systematic Review and Meta-analysis of Efficacy and Cost.
PubMed 文献 · Ann Vasc Surg · 2018-08-04

该系统综述与Meta分析纳入5项随机试验共175,085名男性(年龄64-83岁,平均随访10.6年),评估腹主动脉瘤筛查的疗效与成本效益。筛查显著降低全因死亡率(HR 0.97)、AAA相关死亡率(HR 0.65)和急诊AAA修复(RR 0.64),每预防1例AAA相关死亡需筛查209-769人,16项成本效益分析平均16,854美元/QALY。作者认为应考虑在老年男性中更广泛实施人群AAA筛查。

要点

  • 筛查显著降低全因死亡率(HR 0.97,95%CI 0.96-0.99,P=0.002)和AAA相关死亡率(HR 0.65,95%CI 0.48-0.89,P=0.008)。
  • 筛查显著降低急诊AAA修复(RR 0.64,95%CI 0.46-0.91,P=0.02)。
  • 每预防1例AAA相关死亡需筛查209-769人,16项成本效益分析平均16,854美元/QALY。

核心结论

  • 作者认为应考虑在老年男性中更广泛实施人群腹主动脉瘤筛查项目,因其显示全因死亡率和AAA相关死亡率显著且具成本效益的降低。

研究设计与样本

  • 系统综述与Meta分析,检索Medline、Embase、CENTRAL及相关引文列表,纳入男性AAA筛查的随机试验和成本效益分析。
  • 共纳入5项研究,合计175,085名参与者,年龄64-83岁,平均随访10.6年(范围4.4-13.1年)。
  • Meta分析采用随机效应逆方差加权模型处理连续变量,事件数据采用Mantel-Haenszel加权。

主要发现

  • AAA检出率为3.3%至7.7%。
  • 筛查显著降低全因死亡率(HR 0.97,95%CI 0.96-0.99,P=0.002)。
  • 筛查显著降低AAA相关死亡率(HR 0.65,95%CI 0.48-0.89,P=0.008)。
  • 筛查显著降低急诊AAA修复(RR 0.64,95%CI 0.46-0.91,P=0.02)。
  • 每10年预防1例AAA相关死亡需筛查人数为209至769人;16项成本效益分析平均16,854美元/QALY(范围266-73,369)。

临床怎么用

  • 作者认为应考虑在老年男性中更广泛实施人群腹主动脉瘤筛查项目。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Abdominal aortic aneurysms (AAA) can cause significant mortality when ruptured but are often undiagnosed before this time. Population screening of high-risk individuals and early intervention may mitigate AAA-related mortality. Large trials have demonstrated a mortality benefit for AAA screening, but adoption is not ubiquitous. This study sought to systematically review and consolidate the most recent randomized trial evidence on AAA screening in men and its cost-effectiveness. METHODS: Randomized trials and cost-effectiveness analyses (CEAs) of AAA screening in men were identified from searching Medline, Embase, CENTRAL, and relevant citation lists. Data were extracted as hazard ratios or raw event rates. Meta-analysis was conducted using a random-effects, inverse variance weighted model for continuous variables and Mantel-Haenszel weighting for event data. Cost estimates of screening were adjusted for inflation and reported as $US/quality-adjusted life year. RESULTS: Five studies were identified totaling 175,085 participants (age, 64-83 years) with a mean 10.6 years of follow-up (4.4-13.1). The AAA detection ranged from 3.3 to 7.7%. Screening significantly reduced all-cause mortality (hazard ratio, 0.97; 95% confidence interval, 0.96-0.99; P = 0.002), AAA-related mortality (0.65; 95% confidence interval, 0.48-0.89; P = 0.008), and emergent AAA repair (relative risk, 0.64; 95% confidence interval, 0.46-0.91; P = 0.02). The number needed to screen to prevent 1 AAA-related death per 10 years ranged from 209 to 769 individuals. Sixteen CEAs found a mean 16,854 $/QALY (range, 266-73,369). CONCLUSIONS: Wider implementation of population-based AAA screening programs in elderly men should be considered as it demonstrates a significant and cost-effective reduction in all-cause mortality as well as AAA-related mortality.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Ying AJ, Affan ET. Abdominal Aortic Aneurysm Screening: A Systematic Review and Meta-analysis of Efficacy and Cost. Ann Vasc Surg. 2018. PMID: 30081169. doi:10.1016/j.avsg.2018.05.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。